.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Harvard Business School
UBS
US Department of Justice
Medtronic
Accenture
Daiichi Sankyo
Merck
Fish and Richardson
Novartis

Generated: September 25, 2017

DrugPatentWatch Database Preview

CEFTRIAXONE Drug Profile

« Back to Dashboard

What is the patent landscape for Ceftriaxone, and when can generic versions of Ceftriaxone launch?

Ceftriaxone is a drug marketed by Qilu Pharm Co Ltd, Aurobindo Pharma Ltd, Sandoz Inc, Akorn Inc, Lupin, Teva Pharms Usa, Acs Dobfar, Hospira Inc, Hikma Farmaceutica, Fresenius Kabi Usa, Samson Medcl, Teva, Bedford, Agila Speclts, Sandoz, Facta Farma, Wockhardt, Cephazone Pharma, B Braun, Baxter Hlthcare, and Sagent Pharms. and is included in thirty-three NDAs.

The generic ingredient in CEFTRIAXONE is ceftriaxone sodium. There are twenty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.

Summary for Tradename: CEFTRIAXONE

Patents:0
Applicants:21
NDAs:33
Suppliers / Packagers: see list27
Bulk Api Vendors: see list22
Clinical Trials: see list107
Patent Applications: see list5,341
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFTRIAXONE at DailyMed

Pharmacology for Tradename: CEFTRIAXONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephazone Pharma
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065294-002Mar 26, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065245-001Feb 15, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INJECTION065231-001Aug 2, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Lupin
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INJECTION065263-001Sep 12, 2006APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065169-004May 9, 2005APRXNoYes► Subscribe► Subscribe► Subscribe
Teva
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065262-001Jun 29, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Bedford
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065465-003Aug 18, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INJECTION065168-001May 17, 2005APRXNoYes► Subscribe► Subscribe► Subscribe
Sandoz
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065169-001May 9, 2005APRXNoYes► Subscribe► Subscribe► Subscribe
Hospira Inc
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065230-003Aug 2, 2005APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Moodys
McKinsey
Argus Health
Cerilliant
Colorcon
US Department of Justice
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot